Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,45009,1829,0.80 [0.72-0.90],0.0001334750598153
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44279,436,0.96 [0.76-1.20],0.6977548510237699
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,49196,337,0.81 [0.63-1.05],0.1096139450899076
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,34009,1593,0.66 [0.58-0.74],2.674216555110729e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49087,228,0.82 [0.61-1.12],0.2183006096406443
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,45904,173,1.05 [0.73-1.51],0.7731549053964231
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51613,226,0.83 [0.61-1.14],0.2492180484038222
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51620,154,0.76 [0.52-1.10],0.14681958905367
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44842,119,0.71 [0.47-1.09],0.1223701322239571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,49915,240,1.03 [0.76-1.40],0.8300165210178048
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49829,154,1.16 [0.79-1.69],0.4525237913808286
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51785,135,0.70 [0.47-1.05],0.0845914087713809
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51773,169,1.00 [0.70-1.44],0.993809144243704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51760,156,0.92 [0.63-1.34],0.6584152669483704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,51070,106,0.87 [0.55-1.37],0.5467646808088316
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49291,836,0.82 [0.70-0.97],0.0184255453965015
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48741,286,0.92 [0.70-1.22],0.5643441827418807
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49029,574,0.80 [0.66-0.97],0.0265320073420265
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",41516,132,0.95 [0.63-1.43],0.7923243910116226
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41497,113,1.55 [0.99-2.41],0.0535807211054623
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",41917,533,0.85 [0.69-1.05],0.1251933448642039
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",41934,550,0.88 [0.71-1.07],0.2032584452819102
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23480,678,1.04 [0.87-1.25],0.6637365646854488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18819,237,0.97 [0.71-1.32],0.8296905696121983
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41489,105,1.60 [1.01-2.52],0.0460920780236948
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,46250,1613,0.87 [0.77-0.98],0.0203479302233879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49188,674,0.95 [0.79-1.14],0.6061426189437
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50853,236,1.10 [0.81-1.49],0.5541959404626946
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51940,225,0.87 [0.64-1.19],0.382965865709144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,51375,135,0.79 [0.53-1.17],0.236844182461804
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51956,136,0.65 [0.44-0.97],0.0342613007618872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Stomach,52052,103,0.61 [0.39-0.96],0.033144003744903
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,51496,599,1.23 [1.01-1.50],0.034934812928517
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51962,220,1.54 [1.12-2.12],0.0077173733100736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51973,182,1.03 [0.73-1.47],0.8602827058987219
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51849,106,1.53 [0.97-2.43],0.0703625105957938
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",51854,105,1.56 [0.98-2.48],0.0587460707900018
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,51683,400,1.04 [0.82-1.32],0.7358157336910417
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,51990,175,0.96 [0.67-1.37],0.8058760330395792
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,51778,370,1.08 [0.85-1.38],0.5301990325718613
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of breast,28000,138,1.26 [0.84-1.89],0.2662381458250248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,27481,1012,1.08 [0.93-1.26],0.3145270239281635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49416,399,0.74 [0.58-0.93],0.0109969422845661
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,48758,719,0.89 [0.75-1.07],0.2128192915437803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,48758,719,0.89 [0.75-1.07],0.2128192915437803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44936,940,0.87 [0.74-1.01],0.0740145226633352
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50945,139,0.96 [0.64-1.43],0.8263719749775913
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51431,170,0.78 [0.55-1.12],0.1754910077509566
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42051,2384,0.64 [0.58-0.71],3.505375546113296e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48956,1096,1.05 [0.90-1.21],0.5501245317763557
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,47356,273,1.03 [0.77-1.37],0.8655558555120608
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49644,226,0.59 [0.43-0.80],0.0006217939839985
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47327,244,1.03 [0.76-1.40],0.837110967691594
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,48206,1123,0.52 [0.45-0.60],2.7312983544628453e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,48170,1087,0.50 [0.43-0.58],8.361029735919972e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,48148,376,0.69 [0.53-0.90],0.0064885513130951
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",48151,372,0.68 [0.52-0.89],0.0044551927012753
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41700,2033,0.62 [0.56-0.69],2.544001831132157e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39934,267,0.73 [0.54-0.97],0.0311451436368306
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41545,1878,0.61 [0.55-0.69],3.211081029291175e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39768,101,0.94 [0.58-1.50],0.7858267919257071
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",39838,171,0.61 [0.43-0.87],0.0059465189619888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,44014,1328,0.74 [0.65-0.84],6.569101765343894e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",43147,461,0.72 [0.58-0.89],0.0030165168739111
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51233,344,0.85 [0.66-1.09],0.189413351281988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51366,249,0.82 [0.62-1.10],0.1882069898090768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,48454,118,0.82 [0.54-1.25],0.3610641470674781
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",51853,118,0.92 [0.61-1.40],0.7049258424951474
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",42804,118,0.80 [0.53-1.22],0.3102904876843341
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Alcohol dependence,48476,140,0.56 [0.38-0.82],0.0030368368206653
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,48366,118,0.53 [0.35-0.80],0.0023864766165735
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42796,110,0.45 [0.29-0.69],0.0002482735145472
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",43352,666,0.72 [0.60-0.87],0.0004759872922826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression,48802,583,0.74 [0.61-0.90],0.0027141579488904
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression or dysthymia,42833,507,0.71 [0.57-0.87],0.001027003560825
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",42945,259,0.77 [0.58-1.03],0.0835032816729217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Other anxiety disorders,49091,135,0.92 [0.61-1.37],0.6664723864282973
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,44486,2999,0.75 [0.68-0.82],2.417343872725578e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40384,271,0.69 [0.52-0.91],0.0096974878429786
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51749,214,0.73 [0.53-1.00],0.053135171905078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49319,979,0.75 [0.65-0.88],0.0002276918130861
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,48648,308,0.80 [0.61-1.04],0.1001795309926883
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,48504,164,0.89 [0.61-1.28],0.5216416382702624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51436,148,0.87 [0.59-1.28],0.4710685313536344
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50359,161,0.50 [0.35-0.71],0.0001082854232611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,48678,338,0.79 [0.61-1.02],0.0681678487032309
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,50879,258,0.77 [0.57-1.03],0.0761259994947509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49671,1357,0.88 [0.77-1.00],0.0524125197442502
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48562,248,0.76 [0.57-1.02],0.0721743980590157
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49098,784,0.96 [0.81-1.14],0.643024983780832
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51439,166,0.64 [0.45-0.91],0.0129725968240284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,51389,116,0.62 [0.40-0.94],0.0242398071388633
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,51046,248,0.75 [0.56-1.00],0.0502536779460712
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50700,743,0.90 [0.75-1.06],0.211801189551579
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50388,431,0.84 [0.67-1.05],0.1256649079237957
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,50110,153,0.90 [0.62-1.32],0.5911069219395785
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50200,243,0.98 [0.73-1.33],0.9138566105275994
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50113,156,0.86 [0.59-1.26],0.4385214640568228
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,44811,327,0.87 [0.67-1.13],0.3022204141581152
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,45290,806,0.84 [0.71-1.00],0.0474264071687513
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50005,441,1.12 [0.89-1.41],0.3282728256464274
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51372,106,1.23 [0.77-1.95],0.3869129044841178
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4438,106,1.78 [1.13-2.80],0.0126773164838309
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",47040,106,1.16 [0.73-1.84],0.5409803038648708
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50664,190,1.03 [0.73-1.46],0.8492899341454422
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50579,105,0.97 [0.61-1.53],0.8871608636646054
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50635,176,1.14 [0.80-1.63],0.4701067991012639
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50933,201,0.98 [0.71-1.37],0.9237517425634012
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,51829,270,0.83 [0.63-1.11],0.2116779051433666
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,50274,202,0.75 [0.54-1.05],0.0908105548120003
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36827,6634,0.69 [0.64-0.74],1.0409073909268277e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50757,136,1.09 [0.72-1.63],0.6900889535907766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38778,4578,0.64 [0.59-0.70],1.7125885582311658e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,38847,4647,0.64 [0.59-0.70],1.1583908389376822e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34363,163,0.68 [0.47-0.99],0.0456815972353422
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47592,2425,0.71 [0.64-0.79],6.313861275086737e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,46622,1455,0.71 [0.63-0.81],1.2658253239525928e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49921,492,0.76 [0.62-0.94],0.0128447233614519
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50398,969,0.70 [0.60-0.81],4.460945208005753e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51774,193,0.73 [0.52-1.02],0.065593874929191
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45768,601,0.64 [0.52-0.77],4.225809897519301e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47060,1929,0.67 [0.60-0.75],1.909223783983823e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50366,221,1.17 [0.85-1.61],0.3453597531408724
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50578,462,1.09 [0.87-1.36],0.4435560969022399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50325,180,0.96 [0.68-1.37],0.8207942422183203
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50327,182,0.97 [0.68-1.37],0.8552179584160733
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34374,174,0.87 [0.61-1.26],0.4656416596941939
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43126,118,1.27 [0.81-1.97],0.2944013489986351
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,43256,248,0.97 [0.72-1.31],0.8432717259737761
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28699,241,0.97 [0.71-1.33],0.8549620470937285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,29345,887,1.13 [0.95-1.34],0.1667494484559014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,43144,136,1.07 [0.71-1.60],0.7601710376543558
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43195,187,1.01 [0.71-1.43],0.955802834927382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49867,417,0.83 [0.66-1.05],0.1207839324300608
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50211,317,0.89 [0.69-1.16],0.4035327168893833
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50280,267,0.89 [0.67-1.19],0.433790457982062
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50434,236,0.92 [0.68-1.25],0.593510677101557
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49642,161,0.48 [0.34-0.68],3.624626677618947e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49743,262,0.50 [0.38-0.65],6.562288854690323e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49054,285,1.05 [0.79-1.39],0.7279525781496856
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49011,242,1.09 [0.80-1.47],0.5963048767846242
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51601,231,1.00 [0.73-1.36],0.9980112773815124
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,49731,962,1.14 [0.98-1.33],0.0938974800585182
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,49593,177,0.88 [0.61-1.25],0.4588118758413915
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41487,4163,0.72 [0.67-0.78],9.646789537451211e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51661,219,0.82 [0.60-1.12],0.2124449306147415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,48228,453,0.76 [0.61-0.95],0.0156041152065284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",48171,396,0.77 [0.61-0.98],0.0338543592767365
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50135,508,0.65 [0.53-0.80],4.6735686913465445e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50124,497,0.65 [0.53-0.80],5.131104132017919e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50412,1234,0.90 [0.79-1.03],0.1289548789500388
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,49368,190,0.78 [0.56-1.10],0.1571143478802366
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,49429,251,0.86 [0.64-1.16],0.3270706788056343
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49972,794,0.96 [0.81-1.14],0.644634515794311
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,49551,373,1.08 [0.85-1.39],0.5164809625955022
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23926,126,0.66 [0.43-1.02],0.0612391462467182
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,46479,2045,0.68 [0.61-0.75],6.409954752070234e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,49642,356,0.55 [0.43-0.70],1.4912649187155165e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49695,409,0.56 [0.44-0.70],3.796894281538039e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49695,409,0.56 [0.44-0.70],3.796894281538039e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",48521,1689,0.74 [0.66-0.83],1.886181683297105e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,37145,1689,0.66 [0.59-0.74],9.305103004231233e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36600,1689,0.66 [0.59-0.74],7.513197859619007e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37120,1664,0.66 [0.58-0.74],8.157878472385006e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51282,182,0.34 [0.25-0.47],2.2958431733431096e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,49035,140,0.27 [0.19-0.39],6.314799921153624e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",51442,140,0.29 [0.20-0.41],1.1914013231003336e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49021,126,0.28 [0.19-0.41],3.3454050825954566e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,47826,223,0.87 [0.64-1.20],0.4031041880087606
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,48085,482,0.77 [0.62-0.95],0.0158267050004535
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,49482,221,0.94 [0.69-1.29],0.7072018049224214
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35372,11765,0.84 [0.79-0.88],1.1813003627188016e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50972,847,0.89 [0.75-1.04],0.1459820875043659
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51977,186,0.95 [0.67-1.34],0.7578823792880525
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,51985,172,0.88 [0.61-1.26],0.4876853764555838
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,50342,217,0.90 [0.66-1.24],0.533639945811127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50326,201,1.12 [0.80-1.56],0.5104282823017194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51958,206,0.90 [0.64-1.24],0.5095334728793379
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50322,197,0.77 [0.56-1.08],0.1304360988517278
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49784,158,0.95 [0.65-1.38],0.7827959915076091
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51813,106,1.02 [0.65-1.61],0.927343535772414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39553,553,0.73 [0.60-0.89],0.0021543918450711
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43374,4374,0.86 [0.79-0.92],6.752354173411777e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,39686,686,0.81 [0.68-0.98],0.0265548705471509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,40405,1405,0.95 [0.83-1.08],0.4235455766512223
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39154,154,0.94 [0.64-1.37],0.7473943593157488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39415,415,0.90 [0.71-1.13],0.3579491742314966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39116,116,0.83 [0.54-1.29],0.4165276504619409
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,39310,310,0.74 [0.56-0.96],0.0243806986780722
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,39252,252,0.78 [0.58-1.05],0.1009714053633926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51767,175,0.77 [0.54-1.09],0.1387730196494256
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,39252,252,0.85 [0.63-1.14],0.2774646541515024
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40648,1648,0.84 [0.75-0.95],0.0053742368647853
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,51720,255,1.30 [0.97-1.75],0.0810578731800107
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,39880,880,0.88 [0.75-1.04],0.1281815175398913
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39344,344,0.75 [0.58-0.97],0.0287238710613367
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51716,314,1.08 [0.83-1.41],0.5763474011856256
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,51670,205,1.32 [0.95-1.84],0.0968705293625625
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,45558,3298,0.86 [0.79-0.94],0.000885954580609
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,43467,1207,0.91 [0.79-1.04],0.1657897383415817
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,42520,260,0.66 [0.49-0.88],0.0047470531655688
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,42466,206,0.80 [0.58-1.11],0.1760702630814705
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,44016,1756,0.85 [0.76-0.96],0.0061364406886082
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50065,1530,0.81 [0.72-0.92],0.0009447624814162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,40718,4062,0.88 [0.81-0.95],0.0009579607142282
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51353,119,0.64 [0.42-0.98],0.0381047393743329
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",51902,164,0.53 [0.37-0.75],0.0003807947531114
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,48699,164,0.52 [0.37-0.74],0.0003192908095035
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48659,124,0.52 [0.35-0.78],0.0017424676893143
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",51766,276,0.51 [0.39-0.66],7.255404337483127e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,48811,276,0.50 [0.38-0.65],5.276687006289621e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48783,248,0.50 [0.37-0.66],1.6408238096601736e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49777,1242,0.90 [0.78-1.03],0.1166802217398871
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49763,1228,0.90 [0.79-1.03],0.1373251576382316
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36857,201,0.80 [0.57-1.11],0.1762455918803666
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal stricture,51102,201,0.83 [0.60-1.15],0.2695155880805339
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36788,132,0.86 [0.57-1.29],0.4568361803034818
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37882,1226,0.77 [0.67-0.88],0.0001586166995917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36994,338,0.85 [0.65-1.10],0.2066029527738001
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,37240,584,0.81 [0.66-0.98],0.0332740366925286
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,48713,524,0.87 [0.71-1.07],0.18272085797795
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51124,179,0.99 [0.70-1.41],0.9727002497132776
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36943,287,1.13 [0.85-1.50],0.394753397765118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36801,145,0.77 [0.52-1.14],0.1933372646842123
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38438,1782,0.87 [0.77-0.97],0.0134966859176976
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,37209,553,0.90 [0.74-1.11],0.3241186915545582
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51095,150,1.24 [0.84-1.83],0.2724113734964322
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,50383,252,0.73 [0.54-0.97],0.0317535606694692
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,50269,138,1.11 [0.74-1.66],0.6078331126086323
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49266,1275,0.78 [0.68-0.89],0.0002778259261544
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,49014,1023,0.80 [0.69-0.93],0.0029190462101525
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,48195,204,0.74 [0.54-1.03],0.0770298244365297
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48096,105,0.63 [0.40-0.98],0.0426505096617693
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,48130,139,0.83 [0.56-1.24],0.3606693152985681
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),51684,139,0.84 [0.56-1.25],0.3816449421718727
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49229,634,0.85 [0.70-1.02],0.0834366061672537
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48739,144,1.12 [0.76-1.66],0.5709406992120682
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,48713,118,1.03 [0.67-1.58],0.906306700757706
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48695,100,1.00 [0.62-1.60],0.996378349810256
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,48996,401,0.71 [0.57-0.90],0.0042304169533239
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,48982,387,0.71 [0.56-0.90],0.0044301105552172
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,45626,3148,0.87 [0.79-0.95],0.0012645607880526
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51116,210,0.92 [0.67-1.27],0.6197905634610263
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51186,919,0.84 [0.72-0.99],0.0323996146535133
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,48804,1174,0.93 [0.81-1.07],0.2828709563561387
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50177,795,0.78 [0.66-0.93],0.0042703624082361
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49560,178,0.87 [0.62-1.24],0.4482241589178781
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49891,509,0.79 [0.64-0.97],0.0262920984005232
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51468,186,1.13 [0.80-1.60],0.4899992371793045
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51425,143,1.02 [0.69-1.51],0.9236639225138144
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51392,110,1.38 [0.88-2.17],0.1571159018867708
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51434,115,0.67 [0.44-1.04],0.0726190475656896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51429,110,0.74 [0.47-1.15],0.1823049455086639
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50380,113,0.63 [0.41-0.96],0.0320894891725798
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,51002,735,0.91 [0.76-1.08],0.2664803444903347
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47820,190,1.06 [0.75-1.49],0.7566164723101003
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47836,206,0.97 [0.69-1.35],0.8455606574116141
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47787,157,0.81 [0.55-1.18],0.2638079710018679
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48077,447,0.90 [0.72-1.13],0.3649322784947716
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48031,401,0.87 [0.68-1.10],0.2327892193619476
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37451,8064,0.89 [0.84-0.95],0.0002254118763582
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40716,4687,0.92 [0.86-1.00],0.0370442255336499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46901,2445,0.92 [0.84-1.02],0.1065635209080222
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36335,306,0.66 [0.51-0.87],0.0027318484006759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36967,938,0.82 [0.70-0.96],0.0114414935872503
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51180,294,0.65 [0.50-0.85],0.0019243986284411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51202,266,0.72 [0.54-0.95],0.0215223845376147
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38356,2327,0.90 [0.81-1.00],0.0466736502139494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",43568,2327,0.90 [0.81-1.00],0.0408961329622528
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36170,141,1.37 [0.91-2.06],0.133217581756543
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50863,137,1.41 [0.93-2.12],0.1024540529750956
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,36477,448,0.87 [0.70-1.09],0.2385452643081117
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36175,146,1.09 [0.73-1.63],0.6633105784095686
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,36596,567,0.97 [0.79-1.20],0.7994461653681997
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51708,279,1.08 [0.81-1.44],0.5911313246353549
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,37101,1072,0.94 [0.81-1.10],0.4361172880484872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,36831,802,0.82 [0.69-0.97],0.0217324263930865
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,38638,2609,1.01 [0.92-1.12],0.7694604633273636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36160,131,0.80 [0.53-1.22],0.2973374888263871
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36505,476,1.02 [0.81-1.27],0.8915959531316976
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36142,113,0.90 [0.57-1.41],0.6318010013249236
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36151,122,0.84 [0.54-1.30],0.4366930969198859
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37012,983,1.07 [0.92-1.25],0.3857568220496836
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36879,850,1.10 [0.93-1.30],0.2540613422026005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40269,563,1.12 [0.92-1.38],0.2577969633653284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50906,258,0.51 [0.38-0.68],4.305695728186451e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50760,112,0.48 [0.31-0.73],0.0005774056089866
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44970,127,1.19 [0.78-1.82],0.4120506331752108
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,45444,601,0.80 [0.66-0.97],0.0222839488016295
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,46727,1884,0.90 [0.81-1.01],0.0680742217161456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45227,384,0.80 [0.63-1.02],0.0678104498509999
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45017,174,0.80 [0.56-1.14],0.218881759612889
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",46326,1483,0.89 [0.78-1.01],0.063183968565555
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44945,102,0.84 [0.53-1.33],0.4527535531149932
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45321,478,0.90 [0.73-1.12],0.3481377418147693
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45049,206,0.68 [0.49-0.95],0.0214777129813737
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45003,160,0.93 [0.64-1.36],0.7172306423320414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45127,284,1.08 [0.82-1.44],0.5830954693553743
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44972,129,1.38 [0.91-2.09],0.1320233450420989
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45466,623,0.83 [0.69-1.00],0.0544207929301975
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45087,631,0.89 [0.73-1.07],0.2076083423469535
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44596,140,0.77 [0.52-1.14],0.1944306433835001
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44631,175,1.31 [0.91-1.88],0.1425077950408349
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44663,207,0.77 [0.56-1.07],0.1219828674087894
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44556,100,0.62 [0.39-0.98],0.040452308774721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44689,233,1.17 [0.86-1.60],0.3130472393137958
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44662,206,1.31 [0.94-1.82],0.1125791704528135
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44989,533,0.94 [0.77-1.16],0.586680391802381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44566,110,1.14 [0.73-1.79],0.5571549707946006
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44613,157,0.75 [0.52-1.09],0.1380303000877633
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44712,256,1.00 [0.75-1.35],0.9882805311840162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44582,126,1.19 [0.78-1.82],0.4086327883766029
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45359,903,0.90 [0.76-1.05],0.1701613812729761
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44796,340,0.91 [0.70-1.17],0.4547021503552599
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44940,484,0.99 [0.80-1.23],0.9309472811732564
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48205,345,0.87 [0.68-1.12],0.2923178828784989
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,48648,788,0.94 [0.79-1.11],0.4766789836966701
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47959,99,0.79 [0.50-1.27],0.3366377971238432
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47978,118,1.40 [0.90-2.18],0.132819743463974
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48067,207,1.14 [0.82-1.59],0.4278347433797496
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41274,8622,0.86 [0.81-0.91],1.78760654799427e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20660,1296,0.95 [0.83-1.09],0.4351945481036542
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,46698,512,0.67 [0.54-0.82],0.0001132365126418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46325,139,0.74 [0.50-1.10],0.1409590889843958
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,46907,109,0.80 [0.51-1.25],0.3297520486431591
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46941,143,0.55 [0.38-0.81],0.0022718057529975
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46931,133,0.65 [0.43-0.97],0.0333439302570482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51284,502,0.82 [0.67-1.02],0.0698883938689724
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51125,146,0.93 [0.63-1.37],0.7221797253851047
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51142,360,0.86 [0.67-1.11],0.2414508999480401
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50957,175,0.93 [0.65-1.32],0.6755946661833184
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,47521,2117,0.82 [0.74-0.92],0.0003058029086245
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,45603,199,0.78 [0.56-1.08],0.1334710206009624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45566,162,0.99 [0.68-1.44],0.9698571573989696
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45963,559,0.83 [0.68-1.01],0.0671613291450499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45636,232,0.83 [0.61-1.14],0.2533310303387908
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,46778,1374,0.80 [0.71-0.91],0.0008399599593455
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19938,574,0.94 [0.77-1.16],0.5771762027464835
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19471,107,0.97 [0.61-1.54],0.8910849633297607
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydrocele,19466,102,0.81 [0.51-1.30],0.3886981414405649
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19529,165,0.90 [0.62-1.31],0.5930627115443352
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19527,163,1.12 [0.77-1.63],0.5399884345267494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19581,217,0.93 [0.68-1.29],0.6772493593707343
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27736,485,1.35 [1.09-1.68],0.0067681942685759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27401,150,1.60 [1.08-2.36],0.0178529374278748
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27422,171,1.07 [0.74-1.54],0.7268134495943646
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27364,113,1.36 [0.87-2.13],0.1765516265325456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27673,565,0.93 [0.76-1.14],0.4862835515933624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27242,134,0.99 [0.66-1.50],0.975403260904376
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27360,252,0.91 [0.68-1.23],0.5476251874339277
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25573,4660,0.93 [0.86-1.00],0.0499119071215435
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,21280,367,1.10 [0.86-1.42],0.4428383326373217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,21011,98,1.47 [0.90-2.40],0.1196428955499631
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21083,170,0.83 [0.58-1.20],0.3239281693738879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21719,806,0.79 [0.67-0.93],0.0052759976928488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21330,417,0.91 [0.72-1.15],0.4121877484361455
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21887,974,0.96 [0.82-1.13],0.6356555014154099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21234,321,1.09 [0.84-1.43],0.5101701661219726
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21359,446,0.88 [0.71-1.11],0.2825504899459053
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,21014,101,1.01 [0.62-1.63],0.9707598906669298
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21104,191,0.61 [0.44-0.86],0.0043650081078977
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",28013,270,0.72 [0.54-0.96],0.024651767344395
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,28025,256,0.73 [0.54-0.97],0.0322808661283566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28051,142,0.70 [0.47-1.03],0.0685763847906505
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",28040,156,0.71 [0.49-1.03],0.0722242606134462
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21061,148,0.85 [0.58-1.25],0.4129477382968805
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21028,115,0.85 [0.54-1.31],0.4565986289270359
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21058,145,0.97 [0.65-1.44],0.8746024537867773
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Irregular menses,27942,474,0.86 [0.69-1.07],0.1646899055958406
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22277,1364,0.92 [0.81-1.05],0.2298440279936399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21803,890,0.97 [0.83-1.15],0.74644923798486
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",28030,197,0.68 [0.49-0.95],0.0237546612655202
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21387,474,0.84 [0.68-1.05],0.1205720856682776
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21247,334,0.98 [0.75-1.28],0.8768908347380494
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21821,908,1.15 [0.98-1.35],0.0976074555224194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female infertility,21028,115,1.14 [0.72-1.82],0.5751913648030087
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",21021,108,1.09 [0.68-1.77],0.713709161301981
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,28047,888,1.35 [1.13-1.62],0.0009982809218422
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28050,1214,1.21 [1.03-1.42],0.0193635106971677
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,28048,487,0.99 [0.79-1.24],0.931888301253892
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27699,138,1.15 [0.76-1.74],0.5082075460772699
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27756,195,0.93 [0.66-1.32],0.7021252513990266
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27731,170,1.03 [0.71-1.49],0.8929131673378154
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28066,168,1.20 [0.82-1.76],0.3441057043405484
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28068,165,1.24 [0.84-1.82],0.2798417504522307
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28066,423,1.02 [0.80-1.31],0.8515520812107877
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27770,127,0.87 [0.57-1.34],0.5380184821234903
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27876,233,1.25 [0.91-1.73],0.1727591535470864
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27308,149,1.69 [1.12-2.55],0.0127829587668391
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27362,203,1.24 [0.87-1.76],0.2272153523292484
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27412,253,0.97 [0.71-1.33],0.8524973076631286
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27307,148,1.32 [0.87-1.99],0.1862866804756732
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27299,140,1.52 [1.00-2.31],0.0491756240491298
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27312,153,1.54 [1.03-2.31],0.0347809213671882
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27071,235,1.51 [1.08-2.11],0.0161268257643296
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27280,444,1.24 [0.97-1.58],0.0848817168943964
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27515,679,1.24 [1.00-1.52],0.045608917018467
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28069,173,0.91 [0.62-1.32],0.6100778790675508
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26594,132,1.25 [0.81-1.92],0.314626128186152
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26939,103,1.43 [0.87-2.34],0.1571090082503422
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28078,346,1.07 [0.82-1.40],0.6152421994455917
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27996,264,1.04 [0.77-1.41],0.8030002344488085
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28064,257,1.03 [0.75-1.40],0.8586365959157101
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28054,247,1.05 [0.76-1.44],0.7694359385965933
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51236,124,1.03 [0.67-1.57],0.8961979952567672
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,46893,1211,0.95 [0.83-1.09],0.4916818755219865
